Private Capital Group’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Private Capital Group’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1K	Buy	+89	New	+$1.53K	﹤0.01%	1827

Other funds holding DICE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Private Capital Group's DICE Position: Q2 2022 in Review

Private Capital Group opened a new position in DICE Therapeutics, Inc. Common Stock (DICE) in Q2 2022: 89 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1827 among its holdings.

80 funds tracked by Wall St. Rank hold DICE as of Q2 2022.

Private Capital Group held 89 shares of DICE Therapeutics, Inc. Common Stock worth $1K as of Q2 2022.
DICE Therapeutics, Inc. Common Stock was a new Private Capital Group position in Q2 2022.
DICE Therapeutics, Inc. Common Stock made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1827 holding.
80 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.